Cite
Comparative pharmacokinetic evaluation of nanoparticle-based vs. conventional pharmaceuticals containing statins in attenuating dyslipidaemia.
MLA
Cordina, Jacob, et al. “Comparative Pharmacokinetic Evaluation of Nanoparticle-Based vs. Conventional Pharmaceuticals Containing Statins in Attenuating Dyslipidaemia.” Naunyn-Schmiedeberg’s Archives of Pharmacology, vol. 397, no. 10, Oct. 2024, pp. 7297–306. EBSCOhost, https://doi.org/10.1007/s00210-024-03140-5.
APA
Cordina, J., Ahmad, I., Nath, R., Abdul Rahim, B., Van, A., Al-Zuhairi, D., Williams, K., Pont, L., Catanzariti, R., Mehndiratta, S., Valdivia-Olivares, R. Y., De Rubis, G., & Dua, K. (2024). Comparative pharmacokinetic evaluation of nanoparticle-based vs. conventional pharmaceuticals containing statins in attenuating dyslipidaemia. Naunyn-Schmiedeberg’s Archives of Pharmacology, 397(10), 7297–7306. https://doi.org/10.1007/s00210-024-03140-5
Chicago
Cordina, Jacob, Isha Ahmad, Rohan Nath, Bahara Abdul Rahim, Andrew Van, Dalya Al-Zuhairi, Kylie Williams, et al. 2024. “Comparative Pharmacokinetic Evaluation of Nanoparticle-Based vs. Conventional Pharmaceuticals Containing Statins in Attenuating Dyslipidaemia.” Naunyn-Schmiedeberg’s Archives of Pharmacology 397 (10): 7297–7306. doi:10.1007/s00210-024-03140-5.